Atıf Formatları
Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. YÜKSEL Et Al. , "Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy," EAACI congress , CENEVRE, Switzerland, 2012

YÜKSEL, H. Et Al. 2012. Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy. EAACI congress , (CENEVRE, Switzerland).

YÜKSEL, H., Aydın, Y. M., COŞKUN, B., AYTAÇ VURUŞKAN, B., Şahin, A. B., YAVAŞCAOĞLU, İ., ... VURUŞKAN, H.(2012). Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy . EAACI congress, CENEVRE, Switzerland

YÜKSEL, HASAN Et Al. "Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy," EAACI congress, CENEVRE, Switzerland, 2012

YÜKSEL, HASAN Et Al. "Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy." EAACI congress , CENEVRE, Switzerland, 2012

YÜKSEL, H. Et Al. (2012) . "Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy." EAACI congress , CENEVRE, Switzerland.

@conferencepaper{conferencepaper, author={HASAN YÜKSEL Et Al. }, title={Clinical efficacy and risk factors associated with adverse reactions in children with asthma or allergic rhinitis receiving subcutaneous allergen immunotherapy}, congress name={EAACI congress}, city={CENEVRE}, country={Switzerland}, year={2012}}